APA (7th ed.) Citation

Ferrer, R., Tyczynski, B., Kreutz, J., Scharf, C., Thielmann, M., Bellgardt, M., . . . Taccone, F. S. (2025). Hemoadsorption therapy in severe rhabdomyolysis: A report from the international, prospective COSMOS (CytOSorb® TreatMent of Critically ill PatientS) registry. Renal Failure, 47(1), 1. https://doi.org/10.1080/0886022X.2025.2600720

Chicago Style (17th ed.) Citation

Ferrer, Ricard, et al. "Hemoadsorption Therapy in Severe Rhabdomyolysis: A Report from the International, Prospective COSMOS (CytOSorb® TreatMent of Critically Ill PatientS) Registry." Renal Failure 47, no. 1 (2025): 1. https://doi.org/10.1080/0886022X.2025.2600720.

MLA (9th ed.) Citation

Ferrer, Ricard, et al. "Hemoadsorption Therapy in Severe Rhabdomyolysis: A Report from the International, Prospective COSMOS (CytOSorb® TreatMent of Critically Ill PatientS) Registry." Renal Failure, vol. 47, no. 1, 2025, p. 1, https://doi.org/10.1080/0886022X.2025.2600720.